alexa Abstract | Continuous Quality Improvement: Adherence to Performance Measures - Implementation of Antiplatelet, Statin, Beta-Blocker and Angiotensin System Blockade Therapy Post Myocardial Infarction, Compliance with ACC/AHA Guidelines

International Journal of Collaborative Research on Internal Medicine & Public Health
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Abstract

Introduction: With improvements in diagnosis and management of acute myocardial infarction (MI) more patients suffering MI are surviving to discharge. Patients with known coronary heart disease are at high risk for recurrent MI, stroke, and death. Thus interventions aimed at secondary prevention are critically important. We assessed compliance with secondary prevention guidelines and describe a strategy for improvement that was recently implemented at our institution.

Methods: We performed a retrospective chart review of 737 consecutive patients who presented to our institution from 2008 to 2010. Data was collected on patient demographics, medications prescribed at the time of discharge, and contraindications to each of the following classes of medications: aspirin, statin, beta blockers, and angiotensin system antagonists.

Results: The average age was 62 years, 67% were male, 74.8% had hypertension, 61.9% had diabetes, 42% were tobacco users, and 59.3% had dyslipidemia. Aspirin was prescribed to 721 (99.4%) patients, 3 (0.4%) had a contraindication. Beta blockers were prescribed to 692 (95.5%) patients, 27 (3.7%) had a contraindication. Angiotensin system inhibitors were prescribed to 587 (81.0%) patients, 61 (8.4%) had a contraindication. A statin was prescribed to 698 (96.6%), 10 (1.3%) had a contraindication.

Discussion: Therapeutic lifestyle changes remain the mainstay for secondary prevention after MI. Several adjunctive medications have demonstrated survival benefit. Given the proven survival benefit, the American Heart Association/American College of Cardiology recommend all patients, in the absence of contraindications, receive these four classes of medications. Our hospital has instituted an electronic prompt that requires the discharging clinician to either order each of these medications or place an order stating the reason why the medication is not prescribed.

Conclusion: As we strive to deliver excellent health care we must strive for 100% compliance with these recommendations. An electronic prompt when discharging patients after a myocardial infarction will likely improve compliance.

To read the full article Peer-reviewed Article PDF image | Peer-reviewed Full Article image

Author(s): Sachin Kumar Amruthlal Jain Timothy R Larsen MohammadNasser I Sam Tandon Shukri David

Keywords

Acute Coronary Syndrome, Secondary Prevention

 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsonline.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsonline.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsonline.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsonline.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsonline.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsonline.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsonline.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsonline.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsonline.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsonline.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsonline.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsonline.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsonline.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsonline.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsonline.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsonline.com

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords